Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis

Leiwen Fu, Bingyi Wang, Tanwei Yuan, Xiaoting Chen, Yunlong Ao, Thomas Fitzpatrick, Peiyang Li, Yiguo Zhou, Yi-Fan Lin, Qibin Duan, Ganfeng Luo, Song Fan, Yong Lu, Anping Feng, Yuewei Zhan, Bowen Liang, Weiping Cai, Lin Zhang, Xiangjun Du, Linghua Li, Yuelong Shu, Huachun Zou, Leiwen Fu, Bingyi Wang, Tanwei Yuan, Xiaoting Chen, Yunlong Ao, Thomas Fitzpatrick, Peiyang Li, Yiguo Zhou, Yi-Fan Lin, Qibin Duan, Ganfeng Luo, Song Fan, Yong Lu, Anping Feng, Yuewei Zhan, Bowen Liang, Weiping Cai, Lin Zhang, Xiangjun Du, Linghua Li, Yuelong Shu, Huachun Zou

Abstract

Objective: To better inform efforts to treat and control the current outbreak with a comprehensive characterization of COVID-19.

Methods: We searched PubMed, EMBASE, Web of Science, and CNKI (Chinese Database) for studies published as of March 2, 2020, and we searched references of identified articles. Studies were reviewed for methodological quality. A random-effects model was used to pool results. Heterogeneity was assessed using I2. Publication bias was assessed using Egger's test.

Results: 43 studies involving 3600 patients were included. Among COVID-19 patients, fever (83.3% [95% CI 78.4-87.7]), cough (60.3% [54.2-66.3]), and fatigue (38.0% [29.8-46.5]) were the most common clinical symptoms. The most common laboratory abnormalities were elevated C-reactive protein (68.6% [58.2-78.2]), decreased lymphocyte count (57.4% [44.8-69.5]) and increased lactate dehydrogenase (51.6% [31.4-71.6]). Ground-glass opacities (80.0% [67.3-90.4]) and bilateral pneumonia (73.2% [63.4-82.1]) were the most frequently reported findings on computed tomography. The overall estimated proportion of severe cases and case-fatality rate (CFR) was 25.6% (17.4-34.9) and 3.6% (1.1-7.2), respectively. CFR and laboratory abnormalities were higher in severe cases, patients from Wuhan, and older patients, but CFR did not differ by gender.

Conclusions: The majority of COVID-19 cases are symptomatic with a moderate CFR. Patients living in Wuhan, older patients, and those with medical comorbidities tend to have more severe clinical symptoms and higher CFR.

Keywords: COVID-19; Clinical characteristics; Meta-analysis; Systematic review.

Conflict of interest statement

Declaration of Competing Interest The authors declare having no conflict of interest related to this work.

Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Figures

Fig. 1
Fig. 1
Flow diagram of publication selection *Figure legend: COVID-19: Corona Virus Disease 2019.
Fig. 2
Fig. 2
Meta-analysis of the prevalence of clinical symptoms among COVID-19 patients.
Fig. 3
Fig. 3
Meta-analysis of the prevalence of laboratory findings among COVID-19 patients.
Fig. 4
Fig. 4
Meta-analysis of the prevalence of chest CT findings, complications, severe cases, and mortality among COVID-19 patients *Figure legend: ARDS=Acute Respiratory Distress Syndrome.

References

    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
    1. WHO main website. (accessed March 2, 2020).
    1. Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
    1. Lu R., Zhao X., Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020
    1. Chan J.F., Yuan S., Kok K.H. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–523.
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020
    1. Guan W.-j., Ni Z.-y., Hu Y., et al. Clinical characteristics of 2019 novel coronavirus infection in China. 2020: 10.1101/2020.02.06.20020974.
    1. National Health Commission of the People's Republic of China. (Assessed on March 2, 2020).
    1. Sun P, Qie S, Liu Z, et al. Clinical characteristics of hospitalized patientswith SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol 2020. doi:.
    1. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol. 2020;41(2):145–151.
    1. Liu Y., Yang Y., Zhang C. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020
    1. Wang Z., Chen X., Lu Y. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined chinese and western medicine treatment. Biosci Trends. 2020
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020
    1. Kui L., Fang Y.Y., Deng Y. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin Med J (Engl) 2020
    1. Chung M, Bernheim A. CT Imaging Features of 2019 Novel Coronavirus(2019-nCoV). Radiology 2020 Apr;295(1):202-207.
    1. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, ofnovel coronavirus-infected pneumonia. N Engl J Med 2020.doi: .
    1. Song F, Shi N, Shan F, et al. Emerging 2019 Novel Coronavirus(2019-nCoV) Pneumonia. Radiology 2020:200274.
    1. Chang, Lin M., Wei L. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020
    1. Chen N., Zhou M., Dong X. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.
    1. Pan Y, Guan H, Zhou S, et al. Initial CT findings and temporal changes inpatients with the novel coronavirus pneumonia (2019-nCoV): a study of 63patients in Wuhan, China. Eur Radiol 2020.doi: .
    1. Pan F, Ye T. Time course of lung changes on chest CT during recovery from2019 novel coronavirus (COVID-19) pneumonia. Radiology 2020:200370.doi: .
    1. Chen L., Liu H.G., Liu W. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia] Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E005.
    1. Zhang M.Q., Wang X.H., Chen Y.L. [Clinical features of 2019 novel coronavirus pneumonia in the early stage from a fever clinic in Beijing] Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E013.
    1. Xu XW, Wu XX, Jiang XG, et al. Clinical findings in a group of patientsinfected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan,China: retrospective case series. BMJ 2020;368:m606.
    1. Wu J., Liu J., Zhao X. Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis. 2020
    1. Xu X., Yu C., Qu J. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur J Nucl Med Mol Imaging. 2020
    1. Chen M., An W., Xia F. Retrospective analysis of COVID-19 patients with different clinical subtypes. Herald of Med. 2020:1–12.
    1. H X., N L., L F. Analysis of Chinese medical characteristics of 35 patients with novel coronavirus pneumonia. J Emergen Tradit Chinese Med. 2020:1–4.
    1. D Y.H., J C.W., Y J. Clinical features and ct signs of early family clustering novel coronavirus pneumonia. J Xi'an Jiaotong Uni. 2020:1–7.
    1. Y X., Y H., Y S. Chest CT features of COVID⁃19. J Pract Med. 2020:1–3.
    1. G L., Z J.P., D Y.H. CT features of patients with imported 2019-nCov-pneumonia. J Xi'an Jiaotong Uni. 2020:1–9.
    1. G X.M., L H., S L. Preliminary explore on ct characteristics of corona virus disease 2019 (COVID-19) Radiol Pract. 2020:1–5.
    1. X K., S L., P X. The clinical features of the 143 patients with COVID-19 in north-east of Chongqing. J Third Military Med Uni. 2020:1–5.
    1. X F, Q M, T Y, et al. Clinical features and treatment analysis of 79 cases ofCOVID-19. Chinese pharmacological bulletin 2020:1–7.
    1. L F.M., D H.L., G X.M. Chest CT performance and clinical characteristics of corona virus disease 2019 (COVID-19) Radiol Pract. 2020:1–3.
    1. L Y.F., Y Z.G., W M. Analysis on chinese medical clinical characteristics of 50 patients with 2019-nCoV-infected pneumonia. Academic Journal of Shanghai University of Traditional Chinese Medicine. 2020:1–5.
    1. T. X, J. L, F. X, et al. Analysis of clinical characteristics of 49 patients with novel coronavirus pneumonia in Jiangxi province. Chinese J Resp Critical Care Med:1–7.
    1. J G., H M., Z Q. CT manifestations and dynamic changes of corona virus disease 2019. Chinese J Med Imaging Technol. 2020:1–6.
    1. C J., Z J., L X. Clinical characteristics and ct signs of corona virus disease 2019 (COVID-19) in the elderly. Med J Wuhan Uni. 2020:1–4.
    1. Y S., W Z., Q E. Analysis of clinical characteristics of 25 patients with coronavirus disease in 2019. Chinese J Integrated Trad Western Med. 2020:1–2.
    1. W J., L J., W Y. Dynamic changes of chest ct imaging in patients with corona virus disease-19 (COVID-19) J Zhejiang Uni (Med Sci) 2020:1–13.
    1. Sun H., Bi Y., Zhu Z. Analysis of Chinese medical characteristics of 88 patients with novel coronavirus pneumonia in Tianjin. J Tradit Chinese Med. 2020:1–4.
    1. X G., A C., Z C. Clinical study on treatment of 34 cases of COVID-19 with combination of traditional Chinese and western medicine. Journal of Traditional Chinese Medicine. 2020:1–7.
    1. W Y., C J., W X. CT image features of asymptomatic patients with novel coronavirus. Med J Wuhan Uni. 2020:1–5.
    1. Xiaobo Yang Y.Y., Xu Jiqian, Shu Huaqing, Xia* Jia'an, Liu* Hong, Wu Yongran, Zhang Lu, Yu Zhui, Fang Minghao, Yu Ting, Wang Yaxin, Shangwen Pan X.Z., Yuan Shiying, Shang You. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in wuhan, china: a single-centered, retrospective, observational study. Lancet Respir Med. 2020
    1. Li X., Pan H., Shu J. Clinical presentations and ct features of imported corona virus disease 2019. Chinese J Med Imaging Technol. 2020:1–4.
    1. Y S.M., C Y.F., ZX W. Analysis of the relationship between clinical features and tongue manifestations of 40 cases with novel coronavirus pneumonia. Beijing J Trad Chinese Med. 2020:1–8.
    1. Z X., L L., D G.C. A preliminary study on the clinical characteristics and Chinese medical syndrome of 42 cases of COVID-19 in Nanjing. J Nanjing Uni Trad Chinese Med. 2020:1–5.
    1. Z F.Y., Z H.F., W B.C. CT findings in 2019 novel coronavirus disease (COVID-19) patients. Med J Wuhan Uni. 2020:1–5.
    1. Z Y.J., C Z., L J. Clinical and epidemiological characteristics of 26 patients diagnosed with novel coronavirus pneumonia. Chinese J Nosocomiol. 2020:1–4.
    1. Liberati A., Altman D.G., Tetzlaff J. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
    1. Stroup D.F., Berlin J.A., Morton S.C. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-anal Observat Stud Epidemiol (MOOSE) Group. Jama. 2000;283:2008–2012.
    1. American National Institute of Health. .
    1. Barendregt J.J., Doi S.A., Lee Y.Y. Meta-analysis of prevalence. J Epidemiol Commun Health. 2013;67:974–978.
    1. Higgins J.P., Thompson S.G., Deeks J.J. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
    1. Egger M., Davey Smith G., Schneider M. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634.
    1. Leung W.K., To K.F., Chan P.K. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011–1017.
    1. Peiris J.S., Chu C.M., Cheng V.C. Clinical progression and viral load in a community outbreak of coronavirus-associated Sars pneumonia: a prospective study. Lancet. 2003;361:1767–1772.
    1. Assiri A., McGeer A., Perl T.M. Hospital outbreak of middle east respiratory syndrome coronavirus. N Engl J Med. 2013;369:407–416.
    1. Chen G., Wu D., Guo W., et al. Clinical and immunologic features in severe and moderate forms of coronavirus disease 2019. 2020:medRxiv2020.02.16.20023903.
    1. Ling Y., Xu S.B., Lin Y.X. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl) 2020
    1. Cai Q, Huang D, Ou P, et al. COVID-19 in a designated infectious diseaseshospitaloutside Hubei province, China. medRxiv 2020.doi: 10.1101/2020.02.17.20024018.
    1. Qian K, Deng Y, Tai Y, et al. Clinical characteristics of 2019 novel infectedcoronavirus pneumonia:a systemic review and meta-analysis. medRxiv 2020.doi: 10.1101/2020.02.14.20021535.
    1. Wei M., Yuan J., Liu Y. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA. 2020
    1. Schurz H., Salie M., Tromp G. The x chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13:2.
    1. Yang Y, Lu Q, Liu M, et al. Epidemiological and clinical features of the 2019novel coronavirus outbreak in China. medRxiv 2020.doi: 10.1101/2020.02.10.20021675.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi